Procept Biorobotics Stock Forward View - Polynomial Regression
| PRCT Stock | USD 27.13 1.01 3.87% |
Momentum
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter -0.31 | EPS Estimate Current Year -1.54 | EPS Estimate Next Year -0.87 | Wall Street Target Price 32.2727 | EPS Estimate Current Quarter -0.32 |
This section relates Procept Biorobotics Corp headline activity to recent price behavior and peer context. Options positioning and short interest are used here to outline sentiment for Procept Biorobotics.
Procept Biorobotics Short Interest Summary
Procept Biorobotics' short interest measures the total number of shares sold short but not yet covered. Rising short interest can signal growing bearish sentiment among institutional and retail investors.
200 Day MA 39.3159 | Short Percent 0.1339 | Short Ratio 3.68 | Shares Short Prior Month 7 M | 50 Day MA 28.8762 |
Procept RSI Snapshot
The Polynomial Regression forecasted value of Procept Biorobotics Corp on the next trading day is expected to be 26.01 with a mean absolute deviation of 0.91 and the sum of the absolute errors of 55.49.Procept Biorobotics Corp Hype vs Price Pattern
Public perception of Procept Biorobotics Corp - captured through news and social media signals - can drive Procept Biorobotics' stock price away from intrinsic value for extended periods. Analyzing these biases provides an edge for contrarian investors.
When Procept Biorobotics' market sentiment is overly bullish relative to its actual financial performance, the stock may be overvalued. Excessively negative sentiment can create buying opportunities for patient investors.
Procept Biorobotics Implied Volatility | 0.8 |
High implied volatility in Procept Biorobotics' options signals that the market anticipates large price swings in Procept Biorobotics stock. Conversely, low implied volatility indicates that investors expect relatively stable price action.
The Polynomial Regression forecasted value of Procept Biorobotics Corp on the next trading day is expected to be 26.01 with a mean absolute deviation of 0.91 and the sum of the absolute errors of 55.49.Procept Biorobotics after-hype prediction price | $ 27.16 |
Hype signals are presented as complementary context to forecasting, technicals, analyst estimates, earnings, and momentum.
Use Historical Fundamental Analysis of Procept Biorobotics to cross-verify projections for Procept Biorobotics. The historical view provides additional context.Rule 16 for the current Procept contract - Pricing Context
Using the Rule 16 heuristic, the current implied volatility suggests an average daily move of about 0.05% for the 2026-04-17 options. This estimate is a volatility reference; at $ 27.13, it implies a move of about $ 0.0136 per day.
Procept Options Open Interest - 2026-04-17
Open interest on Procept Biorobotics summarizes how many option contracts remain open and helps frame liquidity and positioning.
Procept Biorobotics Additional Predictive Modules
Most predictive techniques to examine Procept price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Procept using various technical indicators. When you analyze Procept charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Polynomial Regression Price Forecast For the 16th of March 2026
Given 90 days horizon, the Polynomial Regression forecasted value of Procept Biorobotics Corp on the next trading day is expected to be 26.01 with a mean absolute deviation of 0.91 , mean absolute percentage error of 1.35 , and the sum of the absolute errors of 55.49 .Please note that although there have been many attempts to predict Procept Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Procept Biorobotics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Stock Forecast Pattern
| Backtest Procept Biorobotics | Procept Biorobotics Price Prediction | Research Analysis |
Forecasted Value
This next-day forecast for Procept Biorobotics Corp uses model performance to estimate practical downside and upside boundaries rather than a single point target alone. Investors should still remember that no empirical framework consistently proves that one family of forecasting models will outperform all other approaches in live markets.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Polynomial Regression forecasting method's relative quality and the estimations of the prediction error of Procept Biorobotics stock data series using in forecasting. Note that when a statistical model is used to represent Procept Biorobotics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 118.4139 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.9096 |
| MAPE | Mean absolute percentage error | 0.0315 |
| SAE | Sum of the absolute errors | 55.4853 |
The concept of mean reversion suggests that Procept Biorobotics' price will eventually return toward its long-run average. High prices may deter value investors, while unusually low prices often attract buyers who anticipate a recovery.
After-Hype Price Density Analysis
The price distribution graph for Procept Biorobotics visualizes the statistical uncertainty around our prediction model's output. Investors should interpret the full distribution of Procept Biorobotics' outcomes, not just the central tendency, when making decisions.
Next price density |
| Expected price to next headline |
Estimiated After-Hype Price Volatility
The downside and upside margins for Procept Biorobotics after major news events are estimated from historical precedent. Procept Biorobotics' after-hype downside and upside margins for the prediction period are 22.64 and 31.68, respectively. This approach captures the empirical distribution of Procept Biorobotics' short-term price reactions without assuming any particular model of future behavior.
Current Value
The after-hype framework applied to Procept Biorobotics Corp assumes a 3 months review window and focuses on post-sentiment normalization rather than raw momentum. This view is most useful when investors want to compare sentiment-driven price extension with a more measured post-news scenario.
Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Procept Biorobotics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Procept Biorobotics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Procept Biorobotics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.36 | 4.52 | 0.03 | 0.43 | 10 Events | 8 Events | In 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
27.13 | 27.16 | 0.11 |
|
Hype Timeline
Procept Biorobotics Corp is at this time traded for 27.13. The company has historical hype elasticity of 0.03, and average elasticity to hype of competition of 0.43. Procept is forecasted to increase in value after the next headline, with the price projected to jump to 27.16 or above. The average volatility of media hype impact on the company the price is over 100%. The price appreciation on the next news is projected to be 0.11%, whereas the daily expected return is at this time at -0.36%. The volatility of related hype on Procept Biorobotics is about 376.04%, with the expected price after the next announcement by competition of 27.56. The company reported previous year's revenue of 308.05 M. Net Loss for the year was -95.57 M with profit before overhead, payroll, taxes, and interest of 196.23 M. Given the investment horizon of 90 days the next forecasted press release will be in 10 days. Use Historical Fundamental Analysis of Procept Biorobotics to cross-verify projections for Procept Biorobotics. The historical view provides additional context.Related Hype Analysis
The relationship between Procept Biorobotics and its sector peers means that news affecting one company often reverberates across Procept Biorobotics' competitive landscape. Tracking peer hype helps investors anticipate Procept Biorobotics's likely short-term price behavior.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| TWST | Twist Bioscience Corp | 0.16 | 4 per month | 3.07 | 0.14 | 7.68 | -4.95 | 22.17 | |
| GRDN | Guardian Pharmacy Services | -1.21 | 11 per month | 2.57 | 0.1 | 4.55 | -3.61 | 13.96 | |
| MESO | Mesoblast | -0.08 | 9 per month | 0.00 | -0.07 | 5.49 | -6.32 | 16.58 | |
| BGM | Qilian International Holding | -0.19 | 3 per month | 0.00 | -0.32 | 6.86 | -16.71 | 49.57 | |
| QDEL | Quidel | 1.01 | 7 per month | 0.00 | -0.14 | 4.75 | -6.63 | 25.69 | |
| EWTX | Edgewise Therapeutics | 2.54 | 3 per month | 3.99 | 0.09 | 7.54 | -5.20 | 38.85 | |
| CLOV | Clover Health Investments | 0.04 | 9 per month | 0.00 | -0.1 | 4.41 | -3.86 | 17.39 | |
| AORT | Artivion | 0.97 | 7 per month | 0.00 | -0.11 | 2.77 | -3.60 | 12.84 | |
| INSP | Inspire Medical Systems | 8.57 | 9 per month | 0.00 | -0.26 | 2.73 | -8.74 | 21.84 | |
| SSII | SS Innovations International | 0.21 | 4 per month | 0.00 | -0.02 | 10.84 | -10.08 | 43.77 |
Other Forecasting Options for Procept Biorobotics
Whether a novice or experienced investor, anyone considering Procept needs to understand the dynamics of Procept Biorobotics' price movement. Price charts for Procept Stock contain a significant amount of noise that can distort investment decisions.Procept Biorobotics Related Equities
The following equities are related to Procept Biorobotics within the Health Care space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing Procept Biorobotics against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
| Risk & Return | Correlation |
Procept Biorobotics Market Strength Events
Analyzing market strength indicators for Procept Biorobotics enables investors to understand how the stock performs relative to overall market momentum. These indicators are valuable tools for identifying when to enter or exit positions in Procept Biorobotics Corp.
Procept Biorobotics Risk Indicators
Identifying and analyzing Procept Biorobotics' key risk indicators is a foundational step in projecting how its price may evolve. This process helps investors quantify the risk associated with Procept Biorobotics' and decide how to manage it.
| Mean Deviation | 3.04 | |||
| Standard Deviation | 4.41 | |||
| Variance | 19.48 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Procept Biorobotics
Coverage intensity for Procept Biorobotics Corp matters because narrative visibility can influence sentiment, participation, and volatility around the name. The stronger process compares story flow with performance, theme classification, and the level of short-term market interest.
Contributor Headline
Latest Perspective From Macroaxis
Procept Biorobotics Short Properties
Short sentiment tied to Procept Biorobotics Corp matters because heavier bearish pressure can change how quickly future price expectations become unstable. Used correctly, these measures can help investors decide when hedging or timing discipline may matter more than conviction alone.
| Common Stock Shares Outstanding | 55.7 M | |
| Cash And Short Term Investments | 286.5 M |
Additional Tools for Procept Stock Analysis
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |